Vincent Vanheule

807 total citations
16 papers, 579 citations indexed

About

Vincent Vanheule is a scholar working on Oncology, Immunology and Immunology and Allergy. According to data from OpenAlex, Vincent Vanheule has authored 16 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Immunology and 4 papers in Immunology and Allergy. Recurrent topics in Vincent Vanheule's work include Chemokine receptors and signaling (12 papers), Immune Response and Inflammation (10 papers) and Cell Adhesion Molecules Research (4 papers). Vincent Vanheule is often cited by papers focused on Chemokine receptors and signaling (12 papers), Immune Response and Inflammation (10 papers) and Cell Adhesion Molecules Research (4 papers). Vincent Vanheule collaborates with scholars based in Belgium, Brazil and Austria. Vincent Vanheule's co-authors include Paul Proost, Rik Janssens, Sofie Struyf, Mieke Metzemaekers, Jo Van Damme, Daiane Boff, Anneleen Mortier, Flávio A. Amaral, Nele Berghmans and Mauro Martins Teixeira and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Vincent Vanheule

15 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Vanheule Belgium 11 270 253 191 77 60 16 579
Frank J. Ward United Kingdom 15 474 1.8× 176 0.7× 148 0.8× 26 0.3× 54 0.9× 34 782
C. Colin Brinkman United States 18 441 1.6× 219 0.9× 215 1.1× 23 0.3× 46 0.8× 27 740
Michel Heenen Belgium 14 165 0.6× 180 0.7× 176 0.9× 41 0.5× 81 1.4× 39 524
Thomas M. Yankee United States 16 486 1.8× 126 0.5× 233 1.2× 32 0.4× 48 0.8× 35 897
Nikola Baschuk Australia 14 324 1.2× 212 0.8× 256 1.3× 34 0.4× 187 3.1× 21 739
Maria Diedrichs‐Möhring Germany 19 327 1.2× 73 0.3× 147 0.8× 55 0.7× 135 2.3× 34 824
Ursula Holzer Germany 17 366 1.4× 125 0.5× 183 1.0× 23 0.3× 86 1.4× 45 729
Katrina Nicholes United States 7 163 0.6× 145 0.6× 326 1.7× 26 0.3× 88 1.5× 7 651
Hans‐Peter Dienes Germany 12 260 1.0× 160 0.6× 202 1.1× 28 0.4× 181 3.0× 18 696
Gizette Sperinde United States 8 146 0.5× 78 0.3× 201 1.1× 81 1.1× 127 2.1× 24 458

Countries citing papers authored by Vincent Vanheule

Since Specialization
Citations

This map shows the geographic impact of Vincent Vanheule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Vanheule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Vanheule more than expected).

Fields of papers citing papers by Vincent Vanheule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Vanheule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Vanheule. The network helps show where Vincent Vanheule may publish in the future.

Co-authorship network of co-authors of Vincent Vanheule

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Vanheule. A scholar is included among the top collaborators of Vincent Vanheule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Vanheule. Vincent Vanheule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Soebadi, Mohammad Ayodhia, Mieke Metzemaekers, Nele Berghmans, et al.. (2022). Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide. Clinical & Translational Immunology. 11(2). e1370–e1370. 2 indexed citations
3.
Vanheule, Vincent, Sofie Vandendriessche, Mauro Martins Teixeira, et al.. (2022). The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice. International Journal of Molecular Sciences. 23(17). 9715–9715. 2 indexed citations
4.
Berghmans, Nele, Melissa García‐Caballero, Noëmie Pörtner, et al.. (2021). The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers. 13(20). 5090–5090. 15 indexed citations
5.
Marques, Pedro Elias, Sofie Vandendriessche, Mateus Eustáquio Lopes, et al.. (2021). Inhibition of Drug‐Induced Liver Injury in Mice Using a Positively Charged Peptide That Binds DNA. Hepatology Communications. 5(10). 1737–1754. 13 indexed citations
6.
Vanheule, Vincent, et al.. (2020). Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation. Frontiers in Immunology. 11. 483–483. 94 indexed citations
7.
Janssens, Rik, Daiane Boff, Pieter Ruytinx, et al.. (2018). Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity. Frontiers in Immunology. 9. 1933–1933. 6 indexed citations
8.
Metzemaekers, Mieke, Vincent Vanheule, Rik Janssens, Sofie Struyf, & Paul Proost. (2018). Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. Frontiers in Immunology. 8. 1970–1970. 201 indexed citations
9.
Vanheule, Vincent, Mieke Metzemaekers, Rik Janssens, Sofie Struyf, & Paul Proost. (2018). How post-translational modifications influence the biological activity of chemokines. Cytokine. 109. 29–51. 52 indexed citations
10.
Boff, Daiane, Rik Janssens, Vincent Vanheule, et al.. (2018). The chemokine fragment CXCL9(74–103) diminishes neutrophil recruitment and joint inflammation in antigen-induced arthritis. Journal of Leukocyte Biology. 104(2). 413–422. 19 indexed citations
11.
Vanheule, Vincent, Pieter Ruytinx, Nele Berghmans, et al.. (2018). Anti‐inflammatory effects of the GAG‐binding CXCL9(74‐103) peptide in dinitrofluorobenzene‐induced contact hypersensitivity in mice. Clinical & Experimental Allergy. 48(10). 1333–1344. 10 indexed citations
12.
Vanheule, Vincent, Daiane Boff, Anneleen Mortier, et al.. (2017). CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions. Frontiers in Immunology. 8. 530–530. 31 indexed citations
13.
Janssens, Rik, Anneleen Mortier, Daiane Boff, et al.. (2016). Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo. Oncotarget. 7(38). 62439–62459. 27 indexed citations
14.
Vanheule, Vincent, Rik Janssens, Daiane Boff, et al.. (2015). The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74–103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice. Journal of Biological Chemistry. 290(35). 21292–21304. 53 indexed citations
15.
Vanheule, Vincent, Anneleen Mortier, Sam Noppen, et al.. (2015). Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus. Biochemical Pharmacology. 100. 73–85. 30 indexed citations
16.
Raemdonck, Katrien Van, Nele Berghmans, Vincent Vanheule, et al.. (2014). Angiostatic, tumor inflammatory and anti-tumor effects of CXCL447-70 and CXCL4L147–70 in an EGF-dependent breast cancer model. Oncotarget. 5(21). 10916–10933. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank J. Ward Breakdown of academic impact, for papers by C. Colin Brinkman Breakdown of academic impact, for papers by Michel Heenen Breakdown of academic impact, for papers by Thomas M. Yankee Breakdown of academic impact, for papers by Nikola Baschuk Breakdown of academic impact, for papers by Maria Diedrichs‐Möhring Breakdown of academic impact, for papers by Ursula Holzer Breakdown of academic impact, for papers by Katrina Nicholes Breakdown of academic impact, for papers by Hans‐Peter Dienes Breakdown of academic impact, for papers by Gizette Sperinde
Rankless by CCL
2026